Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097578 · ClinicalTrials.gov registry record
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
A clinical trial, sponsored by Genentech.
- Completed
- Registry status
- 1,953
- Enrollment target
NCT00097578: Completed study, sponsored by Genentech.
NCT00097578 is a clinical trial that has completed, run by Genentech. The registered enrollment target is 1,953 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00097578 has completed, sponsored by Genentech.
- COMPLETED
- Registry status
- 1,953 participants
- Enrollment target
Study Summary
This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose cancer has been either previously untreated or treated \<=4 months prior to enrollment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,953 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-07 |
What the finished NCT00097578 record still lists
NCT00097578 is an observational study that tracks outcomes without assigning an intervention. Its 1,953 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00097578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00097578 about?
NCT00097578 is a clinical study titled "A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma". This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose cancer has been either previously untreated or treated \<=4 months prior to enrollment.
What is the current status of trial NCT00097578?
This trial is currently completed. The enrollment target is 1,953 participants. The study started on 2004-03. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00097578?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06062394 · 1,980 participants · NA
Penn Medicine Healthy Heart
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia